Germany: Rezeptortyrosinkinase II, Federal Court of Justice of Germany, X ZR 124/15, 27 September 2016
September 27, 2017
A data sequence can only be regarded as a product directly obtained by a patent-protected process if it has tangible technical properties that are directly imparted on it by this method, and if the data sequence itself can therefore be appropriate subject-matter of a product patent.
The representation of an experimental result obtained by a patented test method and the information derived therefrom is a presentation of information and does not represent a product that can be protected according to Sec. 9 Clause 2 No. 3 of the German Patent Act.
A full summary of this case has been published on Kluwer IP Law.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
